Takeda Global Visionary Award

2018 Global Visionary Award: Takeda Pharmaceuticals

Announcements, Blog Leave a Comment

Our partners are committed to improving lives through science.

They understand the vital role science plays in creating solutions to the problems we all face and in educating the next generation of leaders. Building scientific capacity globally is critical to everyone’s well-being.

Takeda Pharmaceuticals shares this vision of a healthier world and has formed a strategic partnership with Seeding Labs to help implement the Instrumental Access program.

Through this partnership, Takeda’s R&D organization helps provide scientists with the resources, equipment, and training they need to address their community’s healthcare problems, participate in the fight against global diseases, and teach the next generation of local scientists.

For incorporating Instrumental Access into their Access to Medicines initiative, Takeda Pharmaceuticals was presented with a 2018 Global Visionary Award at Positively Instrumental on March 21.

Takeda globe

Takeda knows that to construct healthy communities, it is imperative that talented scientists in countries with evolving healthcare systems are able to innovate and solve their biggest challenges.

They understand that sustainable change is only possible through investment in science and scientists, everywhere.

Effecting change is a crucial aspect of Takeda’s mission to strive toward better health for people worldwide through leading innovation in medicine.

“Helping to catalyze basic research and early translational medicine can have an enormous impact on strengthening the overall healthcare infrastructure in developing countries.”Dr. Chris Reddick, Vice President, Takeda R&D Access to Medicines

This partnership has inspired others to build similar strategic partnerships and transformed Seeding Labs’ ability to invest in creating a world where all scientists can make a difference.

"Helping to catalyze basic research and early translational medicine can have an enormous impact on strengthening the overall healthcare infrastructure in developing countries. This is an important aspect of our Access to Medicines initiative and why we are excited to partner with Seeding Labs," said Dr. Chris Reddick, Vice President, Takeda R&D Access to Medicines.

At Positively Instrumental, Dr. Felicia Adesina, Instrumental Access 2018 awardee from Lead City University in Nigeria, presented the Global Visionary Award to Dr. Chris Reddick of Takeda (pictured at top with Seeding Labs founder and CEO Nina Dudnik).

Share this Post

Leave a Reply

Your email address will not be published. Required fields are marked *